| Lactose (India) Ltd | 120 Cr. | 95.1 | 205/84.3 | 26.5 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.21 Cr. | 1.68 | 4.29/1.68 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 3,425 Cr. | 315 | 479/192 | 70.9 | 24.3 | 0.21 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.3 Cr. | 43.5 | 87.8/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 59.6 Cr. | 40.7 | 41.6/17.0 | 142 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 66.4 Cr. | 88.1 | 115/69.7 | 17.9 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 54,808 Cr. | 1,941 | 2,286/1,275 | 21.8 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 317 Cr. | 13.0 | 17.2/10.8 | 19.0 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 6.97 Cr. | 11.8 | 14.8/9.25 | 87.1 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 790 Cr. | 1,473 | 1,999/635 | 27.4 | 334 | 0.05 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 90.8 Cr. | 18.2 | 32.0/17.0 | 24.8 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 959 Cr. | 326 | 449/219 | 8.57 | 133 | 0.77 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 2.92 Cr. | 13.9 | 39.0/13.0 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 7.42 Cr. | 2.98 | 8.28/2.11 | 4.22 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 392 Cr. | 404 | 536/211 | 59.3 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,816 Cr. | 1,107 | 1,565/944 | 43.6 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 47.0 Cr. | 0.23 | 1.12/0.22 | 3.09 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 32.1 Cr. | 12.2 | 26.3/11.2 | 15.6 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 7.93 Cr. | 7.85 | 15.8/7.85 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 151 Cr. | 423 | 851/415 | 8.55 | 596 | 0.35 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 75.8 Cr. | 75.8 | 92.5/26.1 | 143 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 12,881 Cr. | 1,231 | 2,452/1,225 | 40.1 | 174 | 0.87 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 22.7 Cr. | 49.7 | 88.7/36.1 | 49.4 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 12.5 Cr. | 5.01 | 7.66/2.97 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 20.0 Cr. | 133 | 153/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 70.6 Cr. | 129 | 144/9.41 | 48.7 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 30.9 Cr. | 41.0 | 73.0/33.0 | 49.9 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.43 Cr. | 21.4 | 24.4/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 7,675 Cr. | 443 | 1,028/441 | 21.8 | 72.4 | 0.27 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 73.8 Cr. | 17.1 | 29.6/16.6 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.4 Cr. | 22.5 | 39.3/17.4 | 49.6 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 86,668 Cr. | 2,099 | 2,727/2,082 | 52.0 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 228 Cr. | 396 | 524/241 | 23.4 | 123 | 1.14 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 61.6 Cr. | 42.9 | 47.9/26.7 | 96.3 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 65,228 Cr. | 1,122 | 1,279/994 | 19.1 | 603 | 0.36 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 143 Cr. | 230 | 303/159 | 137 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 710 Cr. | 71.2 | 115/70.0 | 18.3 | 32.6 | 2.11 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 31.7 Cr. | 24.3 | 42.8/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 13,133 Cr. | 1,602 | 1,902/919 | 58.6 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 3.90 Cr. | 0.59 | 1.14/0.51 | 97.5 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 200 Cr. | 26.1 | 53.8/24.0 | 12.8 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 6.86 Cr. | 11.7 | 19.1/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 132 Cr. | 5.59 | 6.57/2.82 | 306 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 58,585 Cr. | 27,575 | 37,000/25,260 | 38.8 | 1,888 | 1.72 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 7,196 Cr. | 794 | 972/557 | 30.0 | 226 | 0.63 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 186 Cr. | 64.8 | 100/31.3 | 51.8 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 3,978 Cr. | 1,199 | 1,740/752 | | 103 | 0.08 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 21,891 Cr. | 1,349 | 1,870/1,110 | 399 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 629 Cr. | 180 | 330/154 | 14.6 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 61.4 Cr. | 7.38 | 29.4/7.36 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 981 Cr. | 729 | 849/270 | 15.5 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 2,661 Cr. | 378 | 791/374 | 18.3 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,414 Cr. | 1,002 | 1,402/975 | 20.0 | 768 | 1.00 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,34,827 Cr. | 3,982 | 4,125/2,886 | 62.2 | 250 | 0.80 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 731 Cr. | 79.5 | 259/78.6 | | 41.3 | 0.62 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,112 Cr. | 11.9 | 23.5/11.6 | 17.7 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 14,695 Cr. | 384 | 1,328/382 | 42.8 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,054 Cr. | 134 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 3,86,748 Cr. | 1,610 | 1,851/1,547 | 33.5 | 324 | 0.99 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,310 Cr. | 518 | 734/441 | 360 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,805 Cr. | 300 | 360/175 | 34.6 | 81.2 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 5,346 Cr. | 273 | 502/265 | 34.6 | 125 | 0.18 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 8,506 Cr. | 195 | 260/111 | 197 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,278 Cr. | 4,035 | 6,718/3,976 | 25.1 | 340 | 2.89 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,642 Cr. | 2,200 | 2,725/1,772 | 32.7 | 335 | 0.91 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,970 Cr. | 5,400 | 6,739/4,904 | 29.2 | 373 | 2.31 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 160 Cr. | 45.5 | 77.4/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 21,151 Cr. | 4,630 | 5,993/3,701 | 29.9 | 841 | 0.76 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 110 Cr. | 89.4 | 206/81.0 | 11.4 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,227 Cr. | 365 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,537 Cr. | 694 | 1,590/604 | 67.7 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 17,001 Cr. | 13,250 | 19,748/10,060 | 86.8 | 1,263 | 0.09 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 270 Cr. | 13.9 | 40.0/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 15,019 Cr. | 840 | 1,341/660 | 9.76 | 483 | 0.71 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 1,893 Cr. | 34.6 | 70.5/34.4 | 25.1 | 21.8 | 0.58 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 7,667 Cr. | 169 | 276/162 | 21.8 | 59.3 | 0.47 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 77.8 Cr. | 49.2 | 123/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 264 Cr. | 73.8 | 162/71.8 | 129 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 97,886 Cr. | 2,141 | 2,228/1,774 | 22.6 | 430 | 0.56 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 899 Cr. | 449 | 809/447 | 11.2 | 357 | 0.40 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 53,363 Cr. | 988 | 1,141/501 | 78.2 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,122 Cr. | 1,081 | 1,235/596 | 22.9 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 134 Cr. | 60.2 | 114/58.8 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 654 Cr. | 135 | 216/123 | 37.1 | 104 | 2.22 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 553 Cr. | 318 | 500/265 | 20.0 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 15,091 Cr. | 947 | 1,250/802 | 30.4 | 414 | 0.53 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 29,561 Cr. | 1,885 | 1,939/1,303 | 39.2 | 243 | 0.82 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,088 Cr. | 164 | 302/161 | 25.6 | 37.9 | 1.52 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 37,428 Cr. | 1,481 | 1,599/1,168 | 37.8 | 293 | 0.27 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,066 Cr. | 70.4 | 127/57.5 | 17.8 | 59.7 | 1.14 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 25.9/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 867 Cr. | 106 | 124/67.2 | 29.3 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 1,912 Cr. | 207 | 350/190 | | 106 | 0.10 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,470 Cr. | 200 | 457/200 | 245 | 96.9 | 0.70 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,198 Cr. | 1,415 | 2,350/1,243 | 27.3 | 397 | 0.49 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,125 Cr. | 312 | 463/285 | 57.6 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,046 Cr. | 538 | 627/412 | 25.5 | 164 | 0.28 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 54,808 Cr. | 1,941 | 2,286/1,275 | 21.8 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 38,647 Cr. | 2,278 | 3,516/1,921 | 40.5 | 101 | 1.84 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 27,908 Cr. | 1,693 | 2,131/1,200 | 24.1 | 610 | 1.06 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,101 Cr. | 375 | 528/359 | 27.1 | 149 | 1.33 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 19,208 Cr. | 1,385 | 1,910/1,097 | 46.2 | 227 | 0.53 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 96,567 Cr. | 1,157 | 1,380/1,020 | 17.3 | 432 | 0.69 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,397 Cr. | 218 | 322/178 | 22.7 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,10,676 Cr. | 1,370 | 1,673/1,310 | 20.3 | 408 | 0.95 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 13,263 Cr. | 1,739 | 2,397/1,551 | 22.5 | 416 | 0.34 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 192 Cr. | 65.1 | 174/64.0 | 13.7 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,629 Cr. | 154 | 196/105 | 14.9 | 107 | 0.32 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 50.0 Cr. | 30.0 | 59.0/28.5 | 17.5 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 59,187 Cr. | 365 | 425/291 | 125 | 200 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,507 Cr. | 1,492 | 2,000/1,430 | 33.3 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 110 Cr. | 68.6 | 129/67.2 | 16.2 | 49.2 | 1.75 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 268 Cr. | 112 | 205/67.8 | 25.3 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 20,646 Cr. | 8,258 | 10,691/6,502 | 89.3 | 320 | 0.39 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,776 Cr. | 612 | 791/544 | 31.3 | 118 | 0.75 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 132 Cr. | 62.7 | 137/61.0 | 7.02 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 67,648 Cr. | 5,656 | 5,934/4,492 | 28.8 | 1,116 | 0.80 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 14,980 Cr. | 762 | 1,108/725 | 23.6 | 271 | 1.44 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 394 Cr. | 686 | 1,250/684 | | 690 | 0.73 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 33,900 Cr. | 2,713 | 3,080/2,022 | 34.8 | 345 | 1.03 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,052 Cr. | 273 | 367/258 | 20.7 | 133 | 1.91 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,416 Cr. | 374 | 575/312 | 17.9 | 147 | 0.27 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 19,408.97 Cr | 1,083.57 | | 50.43 | 202.18 | 0.38% | 16.29% | 15.20% | 6.10 |